Sec Form 13G Filing - PLATINUM INVESTMENT MANAGEMENT LTD filing for KAZIA THERAPEUTICS LTD ADR LEV (KZIA) - 2024-11-06

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>



Schedule 13G


Name of issuer: Kazia Therapeutics Ltd

	Title of class of securities: Sponsored ADR

	Cusip: 48669G105

	Date of event which requires filing: 09/30/2024

	Rule 13d-1(b)

	1.	Platinum Investment Management Limited

	2.	(b)

	3.

	4.	Sydney Australia

	5.	Platinum Investment Management Limited
		0 	(0%)
		Note:Combined total of underlying managed funds


	6.	N/A

	7.	Platinum Investment Management Limited
		0	(0%)
		Note:Combined total of underlying managed funds

	8.	N/A

	9.	0

	10.	No

	11.	0%

	12.	IA



Item 1.

(a) 	Kazia Therapeutics Ltd

(b)     Three International Towers,
	Level 24, 300 Barangaroo Avenue,
	SYDNEY, NSW, Australia, 2000



Item 2.

(a) Platinum Investment Management Limited

(b) Level 8, 7 Macquarie Place
    Sydney NSW 2000
    Australia
(c) Australia
(d) Sponsored ADR
(e) 48669G105

Item 3.
(e) An IA in accordance with Section 240.13d-1(b)(1)(ii)(e)

Item 4.

(a) 0
(b) 0%
(c) (i) 0
(ii) 0
(iii) 0
(iv) 0

Item 5
Yes

Item 6
The clients of Platinum Investment Management Ltd including pooled
investment vehicles and other managed accounts have the right to
receive or power to direct the receipt of dividends from, and the
proceeds from the sale of, Kazia Therapeutics Ltd.

Item 7
N/A

Item 8
N/A

Item 9
N/A



Item 10
(a) By signing below, I certify that to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
(b) N/A


After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.